Current Challenges of R/R MM Management and Innovation Updates
ASCO® 2023 Insights: "TRIMM-2 Study Summary - Update on Talquetamab + Daratumumab for R/R MM"
By
ecancer
FEATURING
Bhagirathbhai Dholaria
By
ecancer
FEATURING
Bhagirathbhai Dholaria
Login to view comments.
Click here to Login
Current Challenges of R/R MM Management and Innovation Updates